Total Payments
$30,074
2024 Payments
$200.06
Companies
10
Transactions
31
Medicare Patients
9,966
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$17,557 (58.4%)
Travel$11,461 (38.1%)
Food & Beverage$1,056 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,557 | 5 | 58.4% |
| Travel and Lodging | $11,461 | 9 | 38.1% |
| Food and Beverage | $1,056 | 17 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optos, Inc. | $11,488 | 9 | $0 (2017) |
| Genentech USA, Inc. | $9,467 | 5 | $0 (2022) |
| Novo Nordisk AS | $7,560 | 1 | $0 (2022) |
| Genentech, Inc. | $698.62 | 3 | $0 (2019) |
| Alcon Vision LLC | $308.24 | 2 | $0 (2024) |
| AbbVie Inc. | $161.78 | 7 | $0 (2023) |
| Allergan, Inc. | $125.00 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $125.00 | 1 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $92.25 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $48.52 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.06 | 1 | Alcon Vision LLC ($200.06) |
| 2023 | $120.27 | 5 | AbbVie Inc. ($120.27) |
| 2022 | $7,646 | 4 | Novo Nordisk AS ($7,560) |
| 2021 | $2,480 | 2 | Genentech USA, Inc. ($2,355) |
| 2020 | $2,480 | 2 | Genentech USA, Inc. ($2,355) |
| 2019 | $806.80 | 4 | Genentech, Inc. ($698.62) |
| 2018 | $4,761 | 3 | Genentech USA, Inc. ($4,712) |
| 2017 | $11,580 | 10 | Optos, Inc. ($11,488) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $200.06 | General |
| 05/08/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: EYE CARE | ||||||
| 03/20/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: EYE CARE | ||||||
| 02/27/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: EYE CARE | ||||||
| 02/08/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: EYE CARE | ||||||
| 01/19/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: EYE CARE | ||||||
| 11/03/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $44.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/16/2022 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $7,560.00 | General |
| 07/20/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: RETINA | ||||||
| 06/01/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: RETINA | ||||||
| 11/18/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/24/2021 | Genentech USA, Inc. | Lucentis (Biological) | Consulting Fee | Cash or cash equivalent | $2,355.00 | General |
| Category: Ophthalmology | ||||||
| 05/21/2020 | Genentech USA, Inc. | Lucentis (Biological) | Consulting Fee | Cash or cash equivalent | $2,355.00 | General |
| Category: Ophthalmology | ||||||
| 02/06/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RETINA | ||||||
| 10/30/2019 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $108.18 | General |
| Category: Ophthalmology | ||||||
| 03/09/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $484.13 | General |
| Category: None | ||||||
| 03/09/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Travel and Lodging | Cash or cash equivalent | $193.29 | General |
| Category: None | ||||||
| 03/09/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: None | ||||||
| 02/24/2018 | Genentech USA, Inc. | Lucentis (Biological) | Consulting Fee | Cash or cash equivalent | $4,600.00 | General |
| Category: Ophthalmology | ||||||
| 02/24/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $112.14 | General |
| Category: Ophthalmology | ||||||
| 02/23/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $48.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/25/2017 | Optos, Inc. | — | Travel and Lodging | Cash or cash equivalent | $437.95 | General |
| 09/25/2017 | Optos, Inc. | — | Travel and Lodging | Cash or cash equivalent | $56.01 | General |
| 09/25/2017 | Optos, Inc. | — | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| 09/25/2017 | Optos, Inc. | — | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,129 | 1,527 | $1.1M | $107,533 |
| 2022 | 18 | 3,433 | 6,071 | $4.5M | $438,915 |
| 2021 | 15 | 3,131 | 5,796 | $4.0M | $422,327 |
| 2020 | 13 | 2,273 | 4,830 | $3.1M | $333,856 |
Total Patients
9,966
Total Services
18,224
Medicare Billing
$1.3M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 452 | 537 | $448,395 | $54,506 | 12.2% |
| 67028 | Injection of drug into eye | Facility | 2023 | 178 | 467 | $423,088 | $32,714 | 7.7% |
| 92250 | Photography of the retina | Office | 2023 | 256 | 272 | $123,760 | $6,782 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 79 | $67,782 | $6,034 | 8.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 26 | 26 | $26,130 | $3,293 | 12.6% |
| 92134 | Imaging of retina | Office | 2023 | 126 | 134 | $39,530 | $3,273 | 8.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 12 | 12 | $7,620 | $930.06 | 12.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 763 | 1,177 | $982,795 | $127,956 | 13.0% |
| 67028 | Injection of drug into eye | Facility | 2022 | 236 | 1,537 | $1.4M | $113,743 | 8.2% |
| 92250 | Photography of the retina | Office | 2022 | 1,193 | 1,891 | $860,095 | $56,545 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 236 | $202,488 | $25,961 | 12.8% |
| 92134 | Imaging of retina | Office | 2022 | 591 | 750 | $221,036 | $25,726 | 11.6% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 18 | 18 | $138,600 | $17,795 | 12.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 14 | 15 | $124,275 | $14,919 | 12.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 90 | 94 | $90,240 | $14,425 | 16.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 102 | 102 | $102,510 | $13,023 | 12.7% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 15 | 15 | $90,600 | $9,834 | 10.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 44 | 44 | $27,940 | $4,912 | 17.6% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 13 | 15 | $83,100 | $4,499 | 5.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 40 | 78 | $61,230 | $3,231 | 5.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 11 | 11 | $39,050 | $2,229 | 5.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $13,020 | $1,752 | 13.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 12 | 12 | $6,960 | $971.96 | 14.0% |
| 92285 | Photography of content of eyes | Office | 2022 | 43 | 45 | $11,070 | $811.99 | 7.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 19 | 19 | $5,605 | $580.33 | 10.4% |
About Dr. Steven Schwartz, MD
Dr. Steven Schwartz, MD is a Ophthalmology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588688444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Schwartz, MD has received a total of $30,074 in payments from pharmaceutical and medical device companies, with $200.06 received in 2024. These payments were reported across 31 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($17,557).
As a Medicare-enrolled provider, Schwartz has provided services to 9,966 Medicare beneficiaries, totaling 18,224 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Beverly Hills, CA
- Active Since 07/26/2006
- Last Updated 08/05/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1588688444
Products in Payments
- Lucentis (Biological) $9,422
- Non-Covered Product (Drug) $698.62
- OZURDEX (Drug) $286.78
- BEOVU (Drug) $125.00
- Constellation (Device) $108.18
- STELLARIS PC (Device) $92.25
- EYLEA AFLIBERCEPT INJECTION (Biological) $48.52
- SUSVIMO (Drug) $44.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Beverly Hills
Dr. Raymond Douglas, Md, Phd, MD, PHD
Ophthalmology — Payments: $1.3M
Ophthalmology $1.3M
Stuart Stoll, Md, MD
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Michael Javaheri, M.d, M.D
Ophthalmology — Payments: $453,983
Ophthalmology $453,983
Kerry Assil, M.d, M.D
Ophthalmology — Payments: $378,371
Ophthalmology $378,371
Afshin Khodabakhsh, Md, MD
Ophthalmology — Payments: $158,563
Ophthalmology $158,563
Christopher Zoumalan, M.d, M.D
Ophthalmology — Payments: $156,708
Ophthalmology $156,708